Epidemiology and complications of late-onset sepsis: an Italian area-based study.
Birth Weight
Catecholamines
/ administration & dosage
Databases, Factual
Female
Fungi
/ isolation & purification
Gestational Age
Gram-Negative Bacteria
/ isolation & purification
Gram-Positive Bacteria
/ isolation & purification
Humans
Infant
Infant, Newborn
Italy
/ epidemiology
Male
Meningitis
/ complications
Premature Birth
Respiration, Artificial
Retrospective Studies
Risk Factors
Sepsis
/ diagnosis
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
16
05
2019
accepted:
03
11
2019
entrez:
23
11
2019
pubmed:
23
11
2019
medline:
21
3
2020
Statut:
epublish
Résumé
Most studies regarding late-onset sepsis (LOS) address selected populations (i.e., neonates with low birth weight or extremely preterm neonates). Studying all age groups is more suitable to assess the burden of single pathogens and their clinical relevance. This is a retrospective regional study involving paediatric departments and NICUs in Emilia-Romagna (Italy). Regional laboratory databases were searched from 2009 to 2012. Records of infants (aged 4 to 90 days) with a positive blood or cerebrospinal fluid (CSF) culture were retrospectively reviewed and analysed according to acquisition mode (whether hospital- or community-acquired). During the study period, there were 146,682 live births (LBs), with 296 patients experiencing 331 episodes of LOS (incidence rate: 2.3/1000 LBs). Brain lesions upon discharge from the hospital were found in 12.3% (40/296) of cases, with death occurring in 7.1% (23/296; 0.14/1000 LBs). With respect to full-term neonates, extremely preterm or extremely low birth weight neonates had very high risk of LOS and related mortality (> 100- and > 800-fold higher respectively). Hospital-acquired LOS (n = 209) was significantly associated with very low birth weight, extremely preterm birth, pneumonia, mechanical ventilation, and death (p< 0.01). At multivariate logistic regression analysis, catecholamine support (OR = 3.2), central venous line before LOS (OR = 14.9), and meningitis (OR = 44.7) were associated with brain lesions or death in hospital-acquired LOS (area under the ROC curve 0.81, H-L p = 0.41). Commonly identified pathogens included coagulase-negative staphylococci (CoNS n = 71, 21.4%), Escherichia coli (n = 50, 15.1%), Staphylococcus aureus (n = 41, 12.4%) and Enterobacteriaceae (n = 41, 12.4%). Group B streptococcus was the predominant cause of meningitis (16 of 38 cases, 42%). Most pathogens were sensitive to first line antibiotics. This study provides the first Italian data regarding late-onset sepsis (LOS) in all gestational age groups. Compared to full-term neonates, very high rates of LOS and mortality occurred in neonates with a lower birth weight and gestational age. Group B streptococcus was the leading cause of meningitis. Excluding CoNS, the predominant pathogens were Escherichia coli and Staphylococcus aureus. Neonates with hospital-acquired LOS had a worse outcome. Antibiotic associations, recommended for empirical treatment of hospital- or community-acquired LOS, were adequate.
Sections du résumé
BACKGROUND
Most studies regarding late-onset sepsis (LOS) address selected populations (i.e., neonates with low birth weight or extremely preterm neonates). Studying all age groups is more suitable to assess the burden of single pathogens and their clinical relevance.
METHODS
This is a retrospective regional study involving paediatric departments and NICUs in Emilia-Romagna (Italy). Regional laboratory databases were searched from 2009 to 2012. Records of infants (aged 4 to 90 days) with a positive blood or cerebrospinal fluid (CSF) culture were retrospectively reviewed and analysed according to acquisition mode (whether hospital- or community-acquired).
RESULTS
During the study period, there were 146,682 live births (LBs), with 296 patients experiencing 331 episodes of LOS (incidence rate: 2.3/1000 LBs). Brain lesions upon discharge from the hospital were found in 12.3% (40/296) of cases, with death occurring in 7.1% (23/296; 0.14/1000 LBs). With respect to full-term neonates, extremely preterm or extremely low birth weight neonates had very high risk of LOS and related mortality (> 100- and > 800-fold higher respectively). Hospital-acquired LOS (n = 209) was significantly associated with very low birth weight, extremely preterm birth, pneumonia, mechanical ventilation, and death (p< 0.01). At multivariate logistic regression analysis, catecholamine support (OR = 3.2), central venous line before LOS (OR = 14.9), and meningitis (OR = 44.7) were associated with brain lesions or death in hospital-acquired LOS (area under the ROC curve 0.81, H-L p = 0.41). Commonly identified pathogens included coagulase-negative staphylococci (CoNS n = 71, 21.4%), Escherichia coli (n = 50, 15.1%), Staphylococcus aureus (n = 41, 12.4%) and Enterobacteriaceae (n = 41, 12.4%). Group B streptococcus was the predominant cause of meningitis (16 of 38 cases, 42%). Most pathogens were sensitive to first line antibiotics.
CONCLUSIONS
This study provides the first Italian data regarding late-onset sepsis (LOS) in all gestational age groups. Compared to full-term neonates, very high rates of LOS and mortality occurred in neonates with a lower birth weight and gestational age. Group B streptococcus was the leading cause of meningitis. Excluding CoNS, the predominant pathogens were Escherichia coli and Staphylococcus aureus. Neonates with hospital-acquired LOS had a worse outcome. Antibiotic associations, recommended for empirical treatment of hospital- or community-acquired LOS, were adequate.
Identifiants
pubmed: 31756213
doi: 10.1371/journal.pone.0225407
pii: PONE-D-19-13900
pmc: PMC6874360
doi:
Substances chimiques
Catecholamines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0225407Déclaration de conflit d'intérêts
This is my amended Competing Interests Statement: Professor Alberto Berardi has received fees (in 2018) from a commercial funder (GSK) for a phone interview. This does not alter adherence to PLOS ONE policies on sharing data and materials. I declare that there are no competing interest concerning the content of this manuscript. I have no further relevant declarations relating to employment, consultancy, patents, products in development, marketed products.
Références
Arch Dis Child Fetal Neonatal Ed. 2011 Jan;96(1):F9-F14
pubmed: 20876594
Arch Dis Child Fetal Neonatal Ed. 2019 May;104(3):F293-F297
pubmed: 29954881
Pediatrics. 2004 Aug;114(2):348-55
pubmed: 15286215
J Med Screen. 2011;18(2):60-4
pubmed: 21852697
MMWR Recomm Rep. 2002 Aug 16;51(RR-11):1-22
pubmed: 12211284
Early Hum Dev. 2012 May;88 Suppl 2:S69-74
pubmed: 22633519
J Pediatr. 2018 Oct;201:106-114.e4
pubmed: 30054165
J Microbiol Immunol Infect. 2004 Oct;37(5):301-6
pubmed: 15497012
J Pediatr. 2015 May;166(5):1193-9
pubmed: 25919728
Pediatr Infect Dis J. 2014 Jan;33(1):e7-e13
pubmed: 23899966
Arch Dis Child Fetal Neonatal Ed. 2015 May;100(3):F257-63
pubmed: 25425653
Pediatrics. 2002 Aug;110(2 Pt 1):285-91
pubmed: 12165580
Arch Dis Child Fetal Neonatal Ed. 2018 Nov;103(6):F547-F553
pubmed: 29208666
Clin Perinatol. 2015 Mar;42(1):29-45, vii-viii
pubmed: 25677995
Pediatr Infect Dis J. 2017 Aug;36(8):774-779
pubmed: 28709162
Am J Infect Control. 2007 Apr;35(3):177-82
pubmed: 17433941
Am J Perinatol. 2015 Jun;32(7):675-82
pubmed: 25486288
Eur J Pediatr. 2012 Apr;171(4):681-7
pubmed: 22134805
J Pediatr. 2013 Jun;162(6):1120-4, 1124.e1
pubmed: 23324523
Pediatrics. 2011 Aug;128(2):e348-57
pubmed: 21768312
Pediatrics. 2005 Sep;116(3):595-602
pubmed: 16140698
J Matern Fetal Neonatal Med. 2017 Jul;30(14):1739-1744
pubmed: 27593156
JAMA. 2004 Nov 17;292(19):2357-65
pubmed: 15547163
Pediatr Infect Dis J. 2000 Jan;19(1):56-65
pubmed: 10643852
MMWR Recomm Rep. 2010 Nov 19;59(RR-10):1-36
pubmed: 21088663
Expert Rev Anti Infect Ther. 2015;13(11):1387-99
pubmed: 26295167
Pediatr Infect Dis J. 2013 Jul;32(7):e265-71
pubmed: 23385951
J Matern Fetal Neonatal Med. 2016 Oct;29(19):3126-31
pubmed: 26515917
Pediatr Infect Dis J. 2017 Sep;36(9):883-888
pubmed: 28178107
Virulence. 2014 Jan 1;5(1):170-8
pubmed: 24185532